KRIs, KPIs and Dashboards to Monitor Wearables, Sensors & BYOD Performance

Published on 21/11/2025

KRIs, KPIs and Dashboards to Monitor Wearables, Sensors & BYOD Performance

The integration of wearables and sensors into clinical trials is a paradigm shift that has the potential to redefine data collection methodologies. To effectively harness this potential, clinical researchers must adopt key performance indicators (KPIs) and key risk indicators (KRIs) that align with their objectives. This step-by-step tutorial aims to provide clinical operations, regulatory affairs, and medical affairs professionals with comprehensive guidance on how to monitor wearables, sensors, and bring-your-own-device (BYOD) performance in clinical trials, particularly in the context of clinical conditions such as Crohn’s disease and ulcerative colitis.

Understanding the Importance of KPIs and KRIs in Clinical Trials

In the implementation of innovative technologies such as wearables and sensors, it is critical to set robust KPIs and KRIs. KPIs help quantify the effectiveness of the chosen methodologies, while KRIs serve to identify potential risks that could impede study execution.

Both KPIs and KRIs should be tailored to the specific objectives of the clinical trial, factoring in the nature of the disease being studied, such as Crohn’s disease clinical trials or ulcerative colitis clinical trials. They should also incorporate considerations for real-world data, which can provide valuable insights into patient adherence and device performance.

Defining KPIs for Wearables and Sensors

KPIs act as benchmarks for assessing operational efficiency and data integrity in clinical trials. When selecting KPIs for wearables and sensors, consider the following metrics:

Device Usage Rate: Percentage of subjects who actively use the wearable/sensor as per protocol requirements.
Data Return Rate: Proportion of data successfully relayed to the central database from connected devices.
Patient Adherence: Measurement of compliance in using wearables as instructed, which can impact data quality.
Device Malfunction Frequency: Rate of any technical issues reported by participants, which could disrupt data integrity.

These KPIs allow investigators to make informed decisions and implement timely interventions to ensure the study’s objectives are achieved efficiently. Each selected KPI should have clear target values to measure against throughout the trial’s duration to facilitate actionable insights.

Establishing KRIs to Mitigate Risks

KRIs focus on potential negative outcomes that could jeopardize study success. To develop your KRIs, consider the following factors:

Drop-out Rate: High participant drop-out rates could indicate issues with protocol adherence or device usability.
Data Quality Issues: Incidents of missing or corrupted data that could impact analysis.
Compliance to Protocol: Non-compliance incidents that can affect the validity of results.
Regulatory Compliance Risks: Any indication that study parameters are not compliant with ICH-GCP or FDA regulations.

By consistently monitoring these KRIs, clinical researchers can proactively address potential pitfalls, ensuring the success of trials leveraging wearables and sensors.

Designing Effective Dashboards for Monitoring

Dashboards serve as a critical tool to visualize both KPIs and KRIs in real time. They enable clinical trial managers to monitor participant data and device performance efficiently. Here’s how to design an effective dashboard for wearables and sensors:

Choosing the Right Dashboard Tools

Select a platform that is compliant with regulatory standards and enables real-time data integration. Options ranging from bespoke solutions to commercial software packages should be assessed based on the specific needs of your trial.

Integration Capability: Ensure the dashboard can seamlessly integrate data from multiple sources, including electronic data capture (EDC) systems and mobile applications.
User-Friendly Interface: A clear and intuitive interface that enables easy navigation for clinical staff.
Real-Time Updates: The capacity to update information dynamically as data comes in from devices.
Analytics Features: Tools that allow for data visualization and reporting, making it easier to spot trends and issues.

Key Features of a Monitoring Dashboard

To maximize effectiveness, an ideal dashboard should present data in a visually clear manner. Include:

Real-time KPI and KRI displays: Use graphs and charts that summarize key metrics for easy monitoring.
Alerts and Notifications: Systems that can alert staff to any deviations from set parameters or thresholds.
Participant Performance Sections: Highlights of individual participant adherence and performance regarding wearables.
Data Quality Reports: Easy access to analytics that report on missing data or inconsistencies.

These features will facilitate effective oversight of participant engagement and device reliability throughout the duration of the clinical trial.

Implementing Real-World Data Collection

Utilizing real-world data in clinical trials is pivotal for understanding the effectiveness of wearables and sensors among diverse patient populations. Data should be collected in a way that supports both clinical insights and regulatory transparency.

Designing Strategies for Real-World Data Collection

To implement effective strategies for real-world data observation:

Treatment Patterns: Capture data on how participants engage with wearables and the effects on their treatment journeys.
Patient-Reported Outcomes (PRO): Integrate surveys and other PRO measures that assess participant perception of their engagement with wearable technology.
Adverse Events Reporting: Ensure a system is in place to report device-related adverse events or complications.

Such strategies ensure a comprehensive dataset that encompasses both clinical outcomes and user experiences, enriching the overall findings and conclusions of the clinical trials.

Compliance and Ethical Considerations

When utilizing real-world data, it is imperative to fulfill ethical obligations surrounding patient privacy and data security. Compliance with regulations, such as GDPR in the EU and HIPAA in the US, cannot be overstated. Adhere to the following principles:

Informed Consent: Ensure participants understand how their data will be used and what technologies will be involved.
Data Anonymization: Implement robust anonymization processes to protect participant identities.
Regulatory Alignment: Stay updated on changes in regulations that govern data privacy and security in clinical research.

By maintaining a strong ethical foundation, you can ensure compliance and enhance participant trust, thereby improving recruitment and retention in the trial.

Conclusion

The integration of wearables and sensors within clinical trials is indeed an exciting advancement, particularly for conditions like Crohn’s disease and ulcerative colitis. By effectively monitoring performance through KPIs and KRIs while employing intuitive dashboards, clinical research professionals can maximize the quality and efficacy of their trials. Coupled with real-world data strategies, the incorporation of these technologies will pave the way to improved patient outcomes and scientific insights, enhancing the overall landscape of clinical research.